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ABSTRACT 
Objective: The current study aims to evaluate the potential of crude leaf extract of Artemisia judaica L. (AJE) in reducing the biochemical 
abnormalities accompanied to alloxan-induced diabetes in male Wistar rats. 
Methods: Thirty male albino rats (100-110 g) were divided equally into three groups including control, diabetic and diabetic+AJE. Diabetes was 
induced by using a single dose of alloxan (120 mg/kg of body weight). Serum biochemical parameters, including insulin, glucose, triglycerides, total 
cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), very low density lipoprotein cholesterol 
(VLDL), total proteins, albumin, globulin, renal markers (creatinine, urea, uric acid), activities of aspartate transaminase (AST), alanine 
transaminase (ALT) and gamma-glutamyltransferase (ɤGT) were measured in all groups. Also, values of homeostasis model assessment of insulin 
resistance (HOMA-IR) and ratios of albumin: globulin (A: G), TC/HDL (risk factor-1), LDL/HDL (risk factor-2) were calculated for each group.  
Results: Diabetic rats showed reduction in body weight and marked decline in the values of serum insulin, protein profile indices and HDL accompanied 
with marked elevation in values of glucose, HOMA_IR, triglycerides, TC, LDL, VLDL, TC/HDL, LDL/HDL, renal markers and activities of the estimated 
enzymes. Supplementation of diabetic rats with AJE, twice daily for 30 days, significantly ameliorated most of the estimated biochemical parameters. 
Conclusion: The current results demonstrate that AJE possesses a hypoglycemic effect and acts as a protective factor against metabolic 
abnormalities induced by diabetes mellitus. 
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INTRODUCTION 
Diabetes mellitus (DM) is a chronic disease characterized by 
hyperglycemia resulting from deficiency of insulin production, insulin 
action, or both [1, 2]. The chronic hyperglycemia of diabetes is 
associated with disturbances in carbohydrate, protein, and fat 
metabolisms, in addition to long-term complications affecting the eyes, 
kidneys, nerves, heart and blood vessels [3-6]. According to WHO, 
about 143 million people worldwide suffering from diabetes and the 
number may likely to double by the year 2030 [7]. The use of plant 
materials for medicinal purposes is an ancient practice which has 
become even more relevant in modern perspective for general health 
and for specific diseases [8]. Recently there is a growing interest in 
herbal remedies due to the side effects associated with the available 
oral hypoglycemic agents for the treatment of diabetes mellitus [9]. 
Also the search for improved, safe and natural antidiabetic agents has 
been recommended by World Health Organization [10].  
Artemisia judaica (family Asteraceae), also known as “ Shih kharasani” 
in Arabic, is a perennial fragrant shrub which grows widely in Sinai 
Peninsula of Egypt. It is widely used in folk medicine and is 
recommended as a healer plant by Bedouins there [11]. Al-Mustafa 
and Al-Thunibat [12] reported that A. judaica is one of medicinal 
plants which has potential of antioxidant activity and used as a 
traditional anti-diabetic agent. The current study was designed to 
evaluate the efficacy of AJE in reducing the metabolic abnormalities 
accompanied to alloxan-induced diabetes in male albino rats. 
MATERIALS AND METHODS 
Plant materials 
Samples of mature fresh green leaves of A. judaica L. were collected 
from the Southern Sinai, Egypt. The plant was identified and 
authenticated by a botanist at the Department of Biological and 
Geological Sciences, Faculty of Education, Ain Shams University, 
Cairo, Egypt. 
Preparation of aqueous extract of A. judaica leaves 
After being thoroughly rinsed with sterile distilled water, leaves of 
shih were ground dried in the shade, and then powdered with a 
blender. Crude hot water extract of the plant leaves was prepared by 
boiling 2g of the plant powder with 200 ml distilled water for 15 
min. The obtained extract was allowed to cool at room temperature 
then filtered through Whatman No.2 filter Paper. The resultant 
extract was stored in a glass container in refrigerator. This extract 
was freshly prepared each two days. 
Experimental animals 
Thirty adult male albino rats of the Wistar strain weighing 100-110g 
and of similar age (8-10 weeks) were obtained from the animal 
house of Theodor Bilharz Research Institute (TBRI), El-Giza, Egypt. 
They were housed in clear plastic cages (2 animals/cage) with wood 
chips as bedding and given a standard pellet rodent diet, in addition 
of water ad libitum. The rats were maintained under standard 
laboratory conditions at 25±2 °C, relative humidity 55±5% and 
normal photoperiod (12h light/dark cycle). All animal experiments 
were performed under protocols approved by the local Institutional 
Animal Ethics Committee of Ain Shams University. 
Induction of diabetes  
Diabetes mellitus was induced in animals by a single intraperitoneal 
injection of alloxan (120 mg/kg body weight) dissolved in freshly 
prepared physiological saline. After three days of alloxan injection, rats 
were deprived of food overnight and they were then given glucose (3 
g/kg body weight) by gastric intubation. After 2h of oral glucose 
administration, blood samples were taken from tail vein and the fasting 
blood glucose (FBG) concentration was determined by means of one 
touch ultra glucometer and compatible blood glucose strips. Animals 
with fasting blood glucose levels ≥ 300 mg/dl were considered as mild 
diabetic animals and included in the experiment. The control rats were 
injected with physiological saline alone as placebo. 
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Experimental protocol 
Experimental animals were divided into three groups (ten for each) 
as follows:  
Group I: (Control group): Untreated non-diabetic rats. 
Group II: (Diabetic group): Rats were injected intraperitoneally with a 
single dose of alloxan (120 mg/kg dissolved in saline solution). 
Group III: Diabetic rats treated orally with AJE (28.5 mg/kg 
twice/day) for 30 days. 
Blood collection 
At the end of the experiment and under diethyl ether anaethesia, 
blood samples were taken from the retro-orbital plexus of the 
overnight fasted animals. Blood samples were centrifuged at 4000 
rpm for 10 min at 4 °C. The clear supernatant sera were quickly 
removed and immediately stored at-80 °C till used for further 
analysis of biochemical parameters. 
Biochemical estimations 
Serum samples were analyzed to estimate the levels of glucose 
according to Tietz [13] and insulin according to Reeves [14]. Insulin 
resistance was estimated using homeostasis model assessment 
(HOMA-IR) from fasting serum glucose and insulin using the 
following equation [15]:  
HOMA-IR = fasting serum glucose (mg/dl) × fasting serum insulin (μU/L)/405  
 
Serum creatinine, urea and uric acid were estimated by colorimetric 
methods according to Tietz [13], while levels of aspartate 
transaminase (AST), alanine transaminase (ALT) and 
glutamyltransferase (γGT) in sera were determined colorimetrically 
following Schumann and Klauke [16]. Serum albumin and total 
proteins were measured according to the method of Burtis et al.[17]. 
Globulin was calculated by subtracting albumin from total proteins 
[13]. Serum total lipids, total cholesterol [18]; triglycerides[19] and 
HDL[20] were estimated colorimetrically using high quality kits 
according to manufacturer's protocol; while VLDL was calculated as 
triglyceride/5 and LDL was calculated applying the Friedwald's 
equation [21].  
Friedewald's equation: LDL (mg/dl) = TC-HDL-[TG/5]. 
Risk factor 1 = TC/HDL  
Risk factor 2 = LDL/HDL  
Statistical analysis 
The results were expressed as mean±SEM of 10 rats per group and the 
statistical significance was evaluated by one way analysis of variance 
(ANOVA) followed by Duncan post Hoc test using the SPSS/17.0 
software. Values were considered statistically significant at P<0.05. 
RESULTS 
Fig. 1. Depicts that diabetic rats showed marked decline (P<0.05) in 
their body weight (-4.55%) when compared to the control group. 
Supplementation of AJE to the diabetic rats for 30 days returned the 
body weight towards normalcy. 
Table 1 shows that levels of insulin were significantly (P<0.05) 
decreased (-38.50%) and levels of glucose were significantly 
(P<0.05) increased (300.50 %) in sera of diabetic rats relative to the 
corresponding control rats. Oral administration of AJE to the 
diabetic rats for one month improved significantly (P<0.05) the 
levels insulin and glucose in sera relative to the control group.  
In addition, HOMA_IR values were significantly higher (P<0.05) in 
diabetic rats (147.19%) when compared to the corresponding 
controls, while treatment of diabetic rats with AJE returned 
HOMA_IR values to normalcy. 
Marked elevations (P<0.05) in the activities of AST (43.81%), ALT 
(49.24%) and γ GT (323.68%) were recorded in sera of the diabetic rats 
when compared to the values of the corresponding controls. On the 
other hand, treatment of diabetic rats with AJE significantly (P<0.05) 
abolished the disturbances occurred in the activities of these enzymes. 
 
 
Fig. 1: Body weight changes in the control and experimental 
male albino rats 
Values are expressed as mean±SEM for 10 rats in each group. 
*P<0.05, AJE: Artemisia judaica extract 
 
Parameters of serum protein profile (total proteins, albumin, globulin 
and A/G ratio) in control and experimental groups are presented in 
table 3. Diabetic animals showed marked decline (P<0.05) in serum 
total proteins (-28.38%), albumin (-26.41%) and globulin (-31.01%) 
relative to the corresponding controls. Treatment of diabetic rats with 
AJE resulted in significant (P<0.05) modulation of the measured serum 
protein profile parameters. The values of A/G ratio showed non-
significant changes between control and experimental groups. 
Table 4 shows the indices of lipid profile in sera of control and 
experimental groups of rats. Diabetic animals showed marked 
elevation (P<0.05) in total lipids (201.69%), total cholesterol 
(64.11%), triglycerides (113.34%), LDL (104.93%), VLDL 
(113.37%) and ratios of TC/HDL (102.66%) and LDL/HDL (159.42) 
accompanied with marked decline in HDL (-20.47 %) relative to the 
corresponding controls. Treatment of diabetic rats with AJE 
improved the sera lipid profile indices. 
Biochemical parameters of renal function elevated markedly 
(P<0.05) in sera of diabetic rats with percentage of change 82.42%, 
95.44% and 248.08% higher than those of control rats for 
creatinine, urea and uric acid, respectively (table 5). Treatment of 
diabetic rats with AJE returned these parameters towards normalcy.  
 
Table 1: Levels of serum insulin and glucose and values of 
HOMA_IR in control and experimental groups 
Parameters Groups 
Control Diabetic Diabetic+AJE 
Insulin (µU/l) 4.13±0.45 2.54±0.37* 3.80±0.68* 
Glucose (mg/dL) 87.44±0.78 350.20±0.85* 94.04±0.62* 
HOMA_IR 0.89±0.23 2.20±0.36* 0.88±0.08 
Values are expressed as mean±SEM for 10 rats in each group. * 
P<0.05, AJE: Artemisia judaica extract, HOMA_IR: homeostasis model 
assessment of insulin resistance. 
 
Table 2: Activities (U/l) of serum AST, ALT and ɤGT in sera of 
control and experimental groups 
Parameters Groups 
Control Diabetic Diabetic+AJE 
AST 37.02±0.59 53.24±1.08* 34.36±0.70* 
ALT 22.46±0.56 33.52±0.60* 28.06±0.55* 
ɤGT 2.28±0.12 9.66±0.08* 4.50±0.07* 
Values are expressed as mean±SEM for 10 rats in each group. * 
P<0.05, AJE: Artemisia judaica extract, AST: aspartate transferase, 
ALT: alanine transferase, ɤGT: gamma-glutamyltransferase. 
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Table 3: Levels of serum proteins (g/dl) and A/G ratio in control and experimental groups 
Parameters Groups 
Control Diabetic Diabetic+AJE 
Total proteins 7.40±0.08 5.30±0.11* 8.20±0.09* 
Albumin 4.24±0.07 3.12±0.06* 4.46±0.05 
Globulin 3.16±0.05 2.18±0.07* 3.72±0.09* 
A/G ratio 1.34±0.05 1.42±0.04 1.22±0.05* 
Values are expressed as mean±SEM for 10 rats in each group. * P<0.05, AJE: Artemisia judaica extract. 
 
Table 4: Levels of serum lipid profile indices (mg/dl) and values of TC/HDL and LDL/HDL ratios in control and experimental groups 
Parameters Groups 
Control Diabetic Diabetic+AJE 
Total lipids 474.00±8.12 1430.00±11.40* 463.60±5.00 
Total cholesterol 141.08±0.37 231.52±0.53* 184.62±0.59* 
Triglycerides 133.10±0.77 283.96±0.86* 147.72±0.45* 
HDL 47.88±0.49 38.08±0.39* 43.70±0.54* 
LDL 66.56±048 136.40±0.59* 111.48±0.61* 
VLDL 26.62±0.16 56.80±0.17* 29.52±0.10* 
TC/HDL 3.00±0.00 6.08±0.04* 4.22±0.06* 
LDL/HDL 1.38±0.02 3.58±0.04* 2.54±0.05* 
Values are expressed as mean±SEM for 10 rats in each group. * P<0.05, AJE: Artemisia judaica extract. HDL: high-density lipoprotein cholesterol, 
LDL: low-density lipoprotein cholesterol, VLDL: very low density lipoprotein cholesterol.  
 
Table 5: levels (mg/dl) of serum creatinine, urea and uric acid in control and experimental groups 
parameters Groups 
Control Diabetic Diabetic+AJE 
Creatinine 0.91±0.01 1.66±0.08* 0.92±0.01 
Urea 32.46±0.55 63.44±0.59* 37.02±0.62* 
Uric acid 2.08±0.06 7.24±0.09* 3.46±0.07* 
Values are expressed as mean±SEM for 10 rats in each group. * P<0.05, AJE: Artemisia judaica extract. 
 
DISCUSSION 
Diabetes mellitus is one of the major diseases affecting many people 
on the globe. Traditional plant based remedies are still the first 
choice in the developing countries because of their cost 
effectiveness, easy availability and minimum or no side effects [22, 
23]. More than 800 plant species have been identified throughout 
the world to have antidiabetic properties [24]. From these medicinal 
plants is Artemisia judaica which is commonly used in folk medicine 
in Egypt. The present investigation was carried out to examine the 
efficacy of AJE in reducing the metabolic abnormalities accompanied 
to alloxan-induced diabetes in male albino rats. 
Induction of diabetes by alloxan resulted in loss of body weight 
reflecting the catabolic effect of diabetes on protein metabolism by 
retarding protein synthesis and stimulating protein degradation 
[25]. In addtion, diabetic rats showed significant decrease (p<0.05) 
in levels of serum insulin accompanied with marked elevation 
(p<0.05) in levels of blood glucose when compared to the control 
rats. This may be due to damages caused by alloxan in beta cells 
which lead to decrease in endogenous insulin secretion. In the same 
context, Szkudelski [26] showed that Alloxan selectively destroys 
the pancreatic insulin secreting β-cells and induces hyperglycemia. 
Treatment of diabetic rats with AJE returned the body weight, 
insulin and glucose levels towards normalcy. These results indicated 
that the AJE possesses significant hypoglycemic and anti-
hypoinsulinemia effects that may be attributed to its content of 
flavonoids, essential oil, saponins, terpenes, and tannins. The 
hypoglycemic action of AJE may be through increase glucose uptake 
and glycogen synthesis, inhibiting for α-glucosidase and α-amylase, 
reduction of insulin resistance, reduction of oxidative stress and 
protecting against tissue damage, generation of beta cells in 
pancreas. These results are in agreement with a previous study 
suggested that A. judaica significantly reduced the blood glucose 
level in diabetic rats [27]. 
Furthermore, a new hormone called Betatrophin found to be 
secreted by liver and adipose tissues. This hormone prompts beta 
cells in the pancreas to multiply and produce more insulin [28]. AJE 
has a variety of chemical constituents such as essential oils 
(artemisyl-oil, apiperitone-oil, piperitone and trans-ethyl 
cinnamate), which have antioxidant, anti-inflammation and anti-
hypo insulinemic activity [29]. Also, these essential oils might be 
stimulating normal beta cells for insulin production enhanced 
peripheral uptake of glucose where insulin increased significantly 
and caused regeneration of hepatocytes [30]. These hepatocytes 
produced more β-trophin enhancing insulin production by β-cells of 
pancreas and enhancing body weight. 
HOMA-IR has considered as a robust tool for the surrogate 
assessment of insulin resistance [31, 32]. In the current study, 
HOMA_IR values were significantly higher (P<0.05) in diabetic rats 
when compared to the corresponding controls. This may be 
attributed to high glucose concentrations leading to the 
development of insulin resistance in peripheral tissues owing to 
impairment of both insulin secretion and insulin sensitivity [33]. 
After AJE administration, the level of HOMA_IR returned to the 
normal values. These findings indicated that AJE exhibited 
antihyperglycemic properties, enhanced insulin release and 
peripheral uptake of glucose in alloxan-induced diabetic rats. 
Activities of ALT, AST and γGT reflect the state of hepatocyte injury 
[34, 35]. In our study, there is an elevation in the activities of these 
enzymes in diabetic rats when compared with the control group 
indicating a state of hepatocyte injury. This may be attributed to 
hyperglycemia which promotes reactive oxygen species (ROS) 
accumulation, accelerates cellular damage and significantly 
contributes to the diabetic complications development and 
progression [36]. Furthermore, an overall significant reduction in 
serum total protein, albumin and globulin in diabetic animal’s 
consequents with slight non-significant elevation in A/G ratio were 
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observed in the present study. These observations are in analogy to 
the results obtained [37] and Chandramohan et al. [38]. 
Hyperglucagonemia during insulin deficiency accelerates protein 
catabolism [39]. This may explain the reduction in serum total 
protein, albumin and globulin in diabetic animals as 
hypoinsulinemia increases the rate of protein degradation and may 
have a direct adverse effect on the synthesis and secretion of 
albumin and globulin. 
Results of the present work showed that, treatment of alloxan-
induced diabetic rats with AJE significantly reduced the activities of 
ALT, AST and γGT and serum protein profile parameters were 
returned back to the normal levels. These results indicated that AJE 
has a hepato protective effect and improving liver function. This may 
be due to the presence of flavonoids (apigenin, cirsimaritin, 
flavonoid glycosides) which have a hypoglycemic action in addition 
to a potent antioxidant action attenuating the oxidative stress 
induced by free radicals, so they can ameliorate the functions of the 
liver by protecting the hepatocytes and inhibiting the production 
proinflammatory mediators like TNF-α, IL-12, IL-2 cytokines which 
has been associated with inflammatory diseases [40]. 
Diabetic animals showed marked elevation (P<0.05) in the values of 
total lipids, total cholesterol, triglycerides, LDL,VLDL and ratios of 
TC/HDL and LDL/HDL accompanied with marked decline in HDL 
relative to the corresponding controls. Insulin has a potent 
inhibitory effect on lipolysis in adipocytes. Therefore, 
hypoinsulinemia is associated with excess lipolysis and increased 
influx of free fatty acids to the liver [41, 42]. This stimulates over 
production of triglycerides, LDL and VLDL by the hepatocytes [41]. 
According to Kinosian et al. [43], the changes in TC/HDL and 
LDL/HDL ratios are better predictors of coronary heart disease than 
the changes in LDL alone. In the present study, diabetic animals 
were subjected to the risk of coronary heart disease as evidenced by 
their high ratios of TC/HDL and LDL/HDL. These observations are 
consistent to earlier results obtained by many investigators [44-46]. 
Results of the current investigation showed that, AJE significantly 
ameliorated all the estimated sera lipid profile indices indicating 
that AJE has potential role of antioxidant activity and it can be used 
as anti-diabetic agent to decrease the risk of atherosclerosis. This 
may be attributed to the flavonoid compounds (apigenin, 
cirsimaritin) which were found in water extracts of A. judaica. These 
compounds act as antioxidants and reduce the levels of cholesterol 
and triglycerides significantly through their protective role against 
free radicals by scavenging activity [30, 47]. 
Elevated levels of blood urea, creatinine and uric acid are likely 
evidence of impaired kidney functions. The obtained results from 
the current study showed high levels of renal markers in sera of 
diabetic rats relative to the corresponding control ones. Renal 
dysfunction indicated by elevation of renal markers in diabetic rats 
has been proved by many investigators [38, 44, 48]. Diabetes 
mellitus is characterized by hyper glycaemia that is strongly linked 
to nephropathy mediated via oxidative stress. This may be due to 
high activities of xanthine oxidase, lipid peroxidation as well as 
impairment of the urea cycle enzyme activities [49]. Treatment of 
diabetic rats with AJE reversed the renal markers towards the 
normal values indicating that A. judaica can ameliorate renal 
function abnormalities and provides protection against the oxidative 
renal damage through the antioxidant capacity of its constituents. 
These findings are in consistence with the results obtained [46] on 
treatment of diabetic rats with aqueous extract of Olea europaea 
plant. Also Chandramohan et al. [38]. Obtained similar results after 
treatment of diabetic rats with 3-hydroxymethyl xylitol for 45 days. 
In conclusion, The present results suggest that AJE has a 
hypoglycemic acts as a beneficial agent against metabolic 
abnormalities induced by diabetes.  
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